ResultsIQ › Latest results › Shree Ganesh Remedies Limited
Shree Ganesh Remedies Limited Q2 FY27 results deck summary
NSE: SGRL · BSE: 540737
Results deck of 1 Nov 2026, summarised by AI from the filing.
Q2 FY27 revenue was ₹23.29 cr (-23% YoY) and PAT ₹1.63 cr (-67%), with management expecting the core business to recover over the next few quarters.
Key takeaways
- Margin fall EBITDA margin fell to 16.9% in Q2 FY27 from 23.3% in Q1 FY27, a fall of 644 bps.
- New products Commercial production of two new pharmaceutical intermediates began, and the first South-East Asia specialty product is expected to supply commercially from Q1 FY28.
Shree Ganesh Remedies Limited earnings call, investor presentation and press release summaries
- Q2 FY27: Results deck (1 Nov 2026)
- Q1 FY27: Results deck (13 Aug 2026)
- Q4 FY26: Results deck (14 May 2026)
- Q3 FY26: Results deck (23 Jan 2026)
- Q2 FY26: Results deck (7 Nov 2025)
- Q1 FY26: Results deck (2 Aug 2025)
- Q4 FY25: Results deck (19 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.